Clinical Trials

Glioblastoma

NCT05638451 2024-06-05

Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients

Glioblastoma

NCT03951142 2023-11-01

ImPRESS

165 enrolled

Brain Neoplasms, Glioblastoma

NCT04671459 2023-06-28

TaRRGET

40 enrolled

Glioblastoma, Recurrence

NCT05191784 2023-06-12

GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients

20 enrolled

Glioblastoma

NCT04223999 2023-06-06

OptimalTTF-2

70 enrolled

Brain Neoplasms, Glioblastoma

NCT02137759 2023-05-06

MRSI to Predict Response to RT/TMZ ± Belinostat in GBM

29 enrolled

Glioblastoma

NCT05447195 2022-07-12

Phase 2 Study of CAN008 in Subjects With GBM

117 enrolled

Glioblastoma

NCT04614493 2022-03-29

SonoFIRST

66 enrolled

Glioblastoma

NCT04888611 2021-11-30

Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma

40 enrolled

Glioblastoma

NCT04874506 2021-05-05

MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)

55 enrolled

Glioblastoma

NCT04715620 2021-01-20

Niraparib Combined With Radiotherapy in rGBM

Glioblastoma

NCT04674527 2020-12-19

Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma

Glioblastoma

NCT04583020 2020-11-30

Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma

42 enrolled

Glioblastoma

NCT04552977 2020-09-17

A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma

50 enrolled

Glioblastoma

NCT04547855 2020-09-14

Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen

54 enrolled

Glioblastoma

NCT01567202 2020-09-09

Study of DC Vaccination Against Glioblastoma

100 enrolled

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT04450160 2020-06-29

AEO

80 enrolled

Glioblastoma, Seizures

NCT02715297 2020-03-10

GlioCave/NOA17

162 enrolled

Glioblastoma, Disease Progression

NCT00276783 2020-03-05

Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases

31 enrolled

CNSLymphoidSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Lymphoma, Neoplasm Metastasis, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT04224441 2020-01-13

RACTAC

41 enrolled

Glioblastoma

NCT04157478 2019-11-12

Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma

464 enrolled

Glioblastoma

NCT03916757 2019-04-17

GBM

20 enrolled

Brain Neoplasms, Glioblastoma

NCT02945826 2018-04-10

uPAR-PET/MRI in Glioblastoma Multiforme

35 enrolled

Glioblastoma

NCT03212235 2017-07-11

Hypofractionated Radiation Therapy for Glioblastoma

58 enrolled

Glioblastoma

NCT02928575 2016-10-10

Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma

45 enrolled

Glioblastoma

NCT02815410 2016-06-28

Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients

73 enrolled

Glioblastoma

NCT02772094 2016-05-13

Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)

50 enrolled

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT02663440 2016-01-26

Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme

41 enrolled

Glioblastoma

NCT01124539 2014-12-09

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

58 enrolled

Glioblastoma, Gliosarcoma

NCT01403311 2014-03-26

ALA

18 enrolled

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Gliosarcoma

NCT00054496 2014-01-10

Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme

73 enrolled

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00492687 2014-01-10

Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas

80 enrolled

Astrocytoma, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00006656 2013-11-06

Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01737346 2012-12-03

Procarbazine and Lomustine in Recurrent Glioblastoma

52 enrolled

Glioblastoma, Recurrence

NCT01124240 2011-07-26

ExCentric

48 enrolled

Glioblastoma

NCT01252459 2010-12-16

GLIAA

200 enrolled

Glioblastoma, Glioma

NCT00562419 2010-10-27

CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan

72 enrolled

Glioblastoma, Central Nervous System Neoplasms

NCT00535379 2010-08-30

SURGE01-07

70 enrolled

Glioblastoma, Recurrence

NCT00643825 2010-07-23

PATSGO

64 enrolled

Glioblastoma

NCT00936052 2010-07-16

HBO

20 enrolled

Glioblastoma, Sarcoma, Gliosarcoma

NCT01083719 2010-03-10

A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.

15 enrolled

Glioblastoma

NCT00906516 2009-05-21

Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme

60 enrolled

Brain Diseases, Brain Neoplasms, Glioblastoma

NCT00114309 2009-04-03

131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma

66 enrolled

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

NCT00521482 2007-08-28

Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma

40 enrolled